The Cigna Group (NYSE:CI) Updates FY 2025 Earnings Guidance

The Cigna Group (NYSE:CI) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided EPS guidance of 29.500- for the period, compared to the consensus EPS estimate of 33.260. The company issued revenue guidance of -.

The Cigna Group Trading Up 0.2 %

NYSE CI opened at $321.34 on Friday. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $87.94 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The business’s 50-day moving average price is $300.07 and its two-hundred day moving average price is $315.72.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the company posted $6.79 EPS. On average, analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were issued a $1.51 dividend. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. This represents a $6.04 annualized dividend and a yield of 1.88%. The Cigna Group’s payout ratio is presently 49.35%.

Analysts Set New Price Targets

Several research firms have recently weighed in on CI. Truist Financial lowered their price objective on The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a research report on Tuesday, February 4th. Oppenheimer dropped their price target on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a research note on Friday, January 31st. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price objective for the company. in a research report on Thursday, February 6th. StockNews.com upgraded shares of The Cigna Group from a “hold” rating to a “buy” rating in a research report on Wednesday, February 19th. Finally, Barclays reduced their price target on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $373.25.

Insider Buying and Selling

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the business’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the transaction, the director now owns 5,471 shares of the company’s stock, valued at approximately $1,697,924.85. The trade was a 30.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 26,527 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now owns 127,767 shares of the company’s stock, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,751 shares of company stock worth $13,603,991. 0.60% of the stock is owned by insiders.

Hedge Funds Weigh In On The Cigna Group

An institutional investor recently raised its position in The Cigna Group stock. Brighton Jones LLC increased its holdings in The Cigna Group (NYSE:CI) by 9.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,736 shares of the health services provider’s stock after buying an additional 318 shares during the period. Brighton Jones LLC’s holdings in The Cigna Group were worth $1,032,000 as of its most recent SEC filing. Institutional investors and hedge funds own 86.99% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.